comprehensive -WSS

comprehensive

author：leisure time 2025-09-02 09:56:09 - browse：55

Vincent Major (left) and Cristina Gonzalez at the prompt-a-thon organized by NYU Langone. Courtesy Joe Carrotta/ NYU Langone

NEW YORK — A fourth-year medical student, a music therapist, a child psychiatrist, and a physician-researcher stared at their laptops, puzzling over the combination of words that would make a supposedly intelligent system — NYU Langone’s customized version of ChatGPT — think about health care problems in a way that was useful to them.

As part of a “prompt-a-thon” in August at the medical center’s science building, the group had been charged with analyzing a patient record around the theme of equity using NYU’s HIPAA-compliant implementation of the buzzy OpenAI technology that can interpret language and generate text based on queries.

After a morning of mini-lectures, participants broke off into assigned groups and dove into NYU Langone’s newly launched prompting interface. Representatives from Microsoft, which makes the artificial intelligence tool accessible through its cloud services, were on hand to ensure everything ran smoothly as about 70 workshop participants from across the academic medical center put prompts into the system around themes including research, clinical applications, and patient education.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Bird flu: Don't repeat Covid's 'health versus the economy' framing

entertainment

WSS

Big Tobacco's 'harm reduction': Is it for real, or a sham?

NVIDIA and Google execs on the future of AI and drug discovery

A virus, fished out of a lake, may have saved a man’s life

NVIDIA and Google execs on the future of AI and drug discovery

Histogen: Failed biotech offers rare public look inside

Anxious about a speech? A startup wants you to pop a minty cardiac drug

hotspot

comprehensive

focus

In age of alternative facts, a scholarly course on calling out crap

Analysis of telehealth claims data suggest service duplication

In age of alternative facts, a scholarly course on calling out crap

Was Amgen transparent enough on FDA's concern on cancer drug?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

NVIDIA and Google execs on the future of AI and drug discovery

BioMarin wins approval for gene therapy to treat hemophilia A

Data integrity in scientific journals requires "effort" by publishers, institutions

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

focus

Senate panel eyes new effort on drug shortages

Colorectal cancer study finds potential in overlooked immune cell

Senate panel eyes new effort on drug shortages

With measles on the rise, a personal story of a devastating disease

What to expect at HLTH 2023, the health care industry conference

Arc Institute generative AI designs new CRISPR systems

entertainment

entertainment

focus

explore